Leerink Swann Lifts Price Target On Array BioPharma (ARRY) to $4
Tweet Send to a Friend
Leerink Swann & Company increases the price valuation from $2-3 to $4 on Array BioPharma Inc. (Nasdaq: ARRY) as MEK ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
